Allurion Technologies, Inc. (NYSE:ALUR) Short Interest Up 124.0% in February

Allurion Technologies, Inc. (NYSE:ALUR) was the recipient of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 1,065,645 shares, an increase of 124.0% from the February 12th total of 475,725 shares. Based on an average daily volume of 17,038,131 shares, the short-interest ratio is presently 0.1 days. Approximately 9.4% of the shares of the stock are short sold. Approximately 9.4% of the shares of the stock are short sold. Based on an average daily volume of 17,038,131 shares, the short-interest ratio is presently 0.1 days.

Allurion Technologies Price Performance

ALUR stock opened at $0.37 on Friday. The firm has a 50 day simple moving average of $1.24 and a two-hundred day simple moving average of $1.60. The stock has a market cap of $4.54 million, a PE ratio of -0.04 and a beta of -0.42. Allurion Technologies has a one year low of $0.23 and a one year high of $4.18.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. State Street Corp increased its stake in Allurion Technologies by 76.2% in the fourth quarter. State Street Corp now owns 26,135 shares of the company’s stock valued at $32,000 after acquiring an additional 11,300 shares during the last quarter. XTX Topco Ltd lifted its stake in Allurion Technologies by 43.2% during the second quarter. XTX Topco Ltd now owns 18,670 shares of the company’s stock worth $45,000 after purchasing an additional 5,633 shares during the last quarter. Hudson Bay Capital Management LP purchased a new position in shares of Allurion Technologies in the 4th quarter worth about $74,000. Heights Capital Management Inc. purchased a new position in shares of Allurion Technologies in the 4th quarter worth about $74,000. Finally, Armistice Capital LLC bought a new position in shares of Allurion Technologies during the 4th quarter valued at about $74,000. 21.39% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on ALUR. Chardan Capital set a $3.00 price target on shares of Allurion Technologies and gave the stock a “buy” rating in a report on Tuesday, February 24th. Weiss Ratings restated a “sell (e+)” rating on shares of Allurion Technologies in a research report on Wednesday, January 21st. Finally, Loop Capital set a $3.00 target price on Allurion Technologies in a research note on Tuesday, February 24th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Allurion Technologies has an average rating of “Hold” and an average price target of $7.33.

Allurion Technologies Company Profile

Allurion Technologies is a medical technology company specializing in non-surgical weight-loss solutions. The company’s flagship product, the Allurion Gastric Balloon, is a swallowable, fluid-filled device designed to promote weight loss by creating a sense of fullness in the stomach. Unlike traditional intragastric balloons, the Allurion device does not require endoscopic insertion or removal, as it self-deflates and is naturally expelled after treatment, simplifying the patient experience and reducing clinical resource requirements.

In addition to its gastric balloon, Allurion has developed a comprehensive digital health platform that integrates wireless tracking devices, a mobile application, and remote coaching to support patients throughout their weight-loss journey.